Review of the incidence and clinical relevance of myeloid antigen-positive acute lympho-blastic leukemia cells
Drexler HG, Thiel E, Ludwig WD (1991) Review of the incidence and clinical relevance of myeloid antigen-positive acute lympho-blastic leukemia cells. Leukemia 5:637-645.
Aminopeptidase N (CD13, EC 3 4.11.2) occurs on the surface of resting and concanavalin A-stimulated lymphocytes
Kunz D, Buhling F, Hiitter H-J, Aoyagi T, Ansorge S (1993) Aminopeptidase N (CD13, EC 3.4.11.2) occurs on the surface of resting and concanavalin A-stimulated lymphocytes. Biol Chem Hoppe-Seyler 374:291-296.
Structural aberrations of the aminopeptidase N (CD13) gene in mono-nuclear cells of patients suffering from leukemia or lymphoma
Lendeckel U, Wex Th, Frank K, Franke A, Ansorge S (1992) Structural aberrations of the aminopeptidase N (CD13) gene in mono-nuclear cells of patients suffering from leukemia or lymphoma. Annals Hematol 65(suppl.):233.
Expression of the aminopeptidase N (CD13) gene in the human T cell lines HuT78 and H9
Lendeckel U, Wex Th, Kahne Th, Frank K, Reinhold D, Ansorge S (1994) Expression of the aminopeptidase N (CD13) gene in the human T cell lines HuT78 and H9. Cell Immunol 153:214-226.
Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukemia
Pinto A, Del-Vecchio L, Carbone A, Roncadin M, Volpe R, Serraino D, Monfardini S, Colombatti A, Zagonel V (1991) Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukemia. Ann Oncol 2:107-113.